247 related articles for article (PubMed ID: 16039577)
1. The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance.
Lazarski CA; Chaves FA; Jenks SA; Wu S; Richards KA; Weaver JM; Sant AJ
Immunity; 2005 Jul; 23(1):29-40. PubMed ID: 16039577
[TBL] [Abstract][Full Text] [Related]
2. The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes.
Sant AJ; Chaves FA; Jenks SA; Richards KA; Menges P; Weaver JM; Lazarski CA
Immunol Rev; 2005 Oct; 207():261-78. PubMed ID: 16181342
[TBL] [Abstract][Full Text] [Related]
3. Immunodominance does not result from peptide competition for MHC class II presentation.
Lo-Man R; Langeveld JP; Martineau P; Hofnung M; Meloen RH; Leclerc C
J Immunol; 1998 Feb; 160(4):1759-66. PubMed ID: 9469434
[TBL] [Abstract][Full Text] [Related]
4. Role of APC in the selection of immunodominant T cell epitopes.
Ma C; Whiteley PE; Cameron PM; Freed DC; Pressey A; Chen SL; Garni-Wagner B; Fang C; Zaller DM; Wicker LS; Blum JS
J Immunol; 1999 Dec; 163(12):6413-23. PubMed ID: 10586031
[TBL] [Abstract][Full Text] [Related]
5. Human immunodeficiency virus-1 reverse transcriptase immunodominant CD4+ T cell epitopes: a peptide-based multiparametric assessment in the mouse.
Borg JP; Ihlenfeldt HG; Jung G; Haas G; Pierres M
Eur J Immunol; 1994 Jul; 24(7):1496-502. PubMed ID: 7517871
[TBL] [Abstract][Full Text] [Related]
6. Bacterial surface proteins recognized by CD4+ T cells during murine infection with Listeria monocytogenes.
Campbell DJ; Shastri N
J Immunol; 1998 Sep; 161(5):2339-47. PubMed ID: 9725229
[TBL] [Abstract][Full Text] [Related]
7. Antigen-presenting cells and the selection of immunodominant epitopes.
Blum JS; Ma C; Kovats S
Crit Rev Immunol; 1997; 17(5-6):411-7. PubMed ID: 9419428
[TBL] [Abstract][Full Text] [Related]
8. Half-life of antigen/major histocompatibility complex class II complexes in vivo: intra- and interorgan variations.
Müller KP; Schumacher J; Kyewski BA
Eur J Immunol; 1993 Dec; 23(12):3203-7. PubMed ID: 8258335
[TBL] [Abstract][Full Text] [Related]
9. Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins.
Castelli FA; Leleu M; Pouvelle-Moratille S; Farci S; Zarour HM; Andrieu M; Auriault C; Ménez A; Georges B; Maillere B
Eur J Immunol; 2007 Jun; 37(6):1513-23. PubMed ID: 17492804
[TBL] [Abstract][Full Text] [Related]
10. Determination of specific CD4 and CD8 T cell epitopes after AAV2- and AAV8-hF.IX gene therapy.
Chen J; Wu Q; Yang P; Hsu HC; Mountz JD
Mol Ther; 2006 Feb; 13(2):260-9. PubMed ID: 16324888
[TBL] [Abstract][Full Text] [Related]
11. Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides.
Ulivieri C; Citro A; Ivaldi F; Mascolo D; Ghittoni R; Fanigliulo D; Manca F; Baldari CT; Li Pira G; Del Pozzo G
Immunol Lett; 2008 Aug; 119(1-2):62-70. PubMed ID: 18538862
[TBL] [Abstract][Full Text] [Related]
12. CD4(+) T cells from healthy subjects and colon cancer patients recognize a carcinoembryonic antigen-specific immunodominant epitope.
Campi G; Crosti M; Consogno G; Facchinetti V; Conti-Fine BM; Longhi R; Casorati G; Dellabona P; Protti MP
Cancer Res; 2003 Dec; 63(23):8481-6. PubMed ID: 14679013
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous presentation and cross-presentation of immune-stimulating complex-associated cognate antigen by antigen-specific B cells.
Robson NC; Donachie AM; Mowat AM
Eur J Immunol; 2008 May; 38(5):1238-46. PubMed ID: 18398931
[TBL] [Abstract][Full Text] [Related]
14. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination.
Zinckgraf JW; Sposato M; Zielinski V; Powell D; Treanor JJ; von Hofe E
Vaccine; 2009 Aug; 27(39):5393-401. PubMed ID: 19596415
[TBL] [Abstract][Full Text] [Related]
15. Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells.
Röhn TA; Schadendorf D; Sun Y; Nguyen XD; Roeder D; Langen H; Vogt AB; Kropshofer H
Eur J Immunol; 2005 Oct; 35(10):2826-39. PubMed ID: 16163671
[TBL] [Abstract][Full Text] [Related]
16. Peptide binding and antigen presentation by class II histocompatibility glycoproteins.
Jensen PE
Biopolymers; 1997; 43(4):303-22. PubMed ID: 9316394
[TBL] [Abstract][Full Text] [Related]
17. Biological activity and therapeutic potential of homologs of an Ii peptide which regulates antigenic peptide binding to cell surface MHC class II molecules.
Adams S; Albericio F; Alsina J; Smith ER; Humphreys RE
Arzneimittelforschung; 1997 Sep; 47(9):1069-77. PubMed ID: 9342425
[TBL] [Abstract][Full Text] [Related]
18. Intercellular exchange of class II MHC complexes: ultrastructural localization and functional presentation of adsorbed I-A/peptide complexes.
Patel DM; Dudek RW; Mannie MD
Cell Immunol; 2001 Nov; 214(1):21-34. PubMed ID: 11902826
[TBL] [Abstract][Full Text] [Related]
19. Kinetic isomers of a class II MHC-peptide complex.
Schmitt L; Boniface JJ; Davis MM; McConnell HM
Biochemistry; 1998 Dec; 37(50):17371-80. PubMed ID: 9860852
[TBL] [Abstract][Full Text] [Related]
20. DM and DO shape the repertoire of peptide-MHC-class-II complexes.
Karlsson L
Curr Opin Immunol; 2005 Feb; 17(1):65-70. PubMed ID: 15653313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]